Market Research Report

Global Cancer Pain Management Market Research Report: Forecast (2024-2030)

Global Cancer Pain Management Market Report - By Drug Class (Opioids, (Morphine Oxycodone, Fentanyl, Others (Methadone, Tapentadol, etc.)), Non-Opioids, (Acetaminophen, Nonsteroida...l Anti-Inflammatory Drugs (NSAIDs)), (Ibuprofen, Naproxen, Others (Diclofenac, Ketorolac, etc.)), Antidepressants, Others (Steroids, Anti-convulsants, etc.)), By Route of Administration (Oral, Injectable, Transdermal, Others (Intranasal, Intrathecal, etc.)), By Cancer Type (Lung Cancer, Breast Cancer, Stomach, Colorectal, Others (Blood Cancer, Prostate Cancer, etc.))), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Homecare, Specialty Clinics, Others (Research Organisations, Palliative Care Centers, etc.)), and Others Read more

  • Healthcare
  • May 2024
  • 171
  • HC22864

Market Definition

Cancer pain management includes both the drugs & therapies provided to cancer patients by the healthcare facilities to provide relief from moderate to severe pain. Some of the major drugs that help in reducing pain include opioids and non-opioid medications like morphine, oxycodone, etc.

Market Insights & Analysis: Global Cancer Pain Management Market (2024-30):

The Global Cancer Pain Management Market is estimated to grow at a CAGR of around 5.60% during the forecast period, i.e., 2024-30. In recent years, the lifestyle of individuals has drastically changed, as individuals nowadays follow hectic & unhealthy lifestyles, along with this there is a rising percentage of the elderly population which is further amplifying the occurrence of chronic diseases, such as cancer. Also, due to several other health concerns, including overweight and obesity, individuals are getting several common cancers, including breast, colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. As a result, the demand for cancer pain management drugs has increased, further enhancing the Cancer Pain Management Market size.

Further, there has been a surge in geriatric individuals in regions, like North America, Asia-Pacific, etc. These aged populations experience higher symptoms of cancer and individuals experience body aches. Therefore, the aged population is shifting towards the pain management solution to minimize their body pain. In addition, the geriatric population has a higher risk of getting cancer-based on several research studies conducted by institutes & cancer centers, like the American Society of Clinical Oncology (ASCO) and others. Therefore, the population suffering from cancer is opting for cancer pain management, including medication & designated therapies.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 5.60%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled Daiichi Sankyo Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals, Inc., Lupin, Forte Bio-Pharma LLC, Mallinckrodt Pharmaceuticals, Collegium Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Napp Pharmaceuticals, Zentiva Group, Mundipharma International, G.L. Pharma, and Others
Market Value (2023) USD Value In Billion

 

In addition, the aged population across the Globe would increase during the forecast period. Based on the statistics provided by the World Health Organization (WHO), the population of individuals aged 60 would reach more than 1 billion in 2030 and more than 2 billion by 2050. As a result, the adoption of cancer pain management drugs would increase, propelling the overall Cancer Pain Management Market in forecast years.

Global Cancer Pain Management Market Driver:

Mounting Cancer Cases Across the Globe Elevating Market Growth – Over the past few years, there has been a surge in cancer cases in regions like North America, Latin America, etc. According to the research conducted by the Global Cancer Observatory, in 2022, the number of new cancer cases reached about 20.1 million. These cancer patients experience headaches & body pain. Therefore, health practitioners prescribe the patients the necessary cancer pain management drugs. Hence, the surging cancer cases across the globe are elevating the requirement for cancer pain management solutions, driving the Global Cancer Pain Management market.

In addition, cancer cases would continue to increase globally due to the growing geriatric population. As a result, the demand for cancer pain management solutions would continue to surge across the globe in the forecast period as well.


Global Cancer Pain Management Market Research Report: Forecast (2024-2030)

Global Cancer Pain Management Market Opportunity:

Rising Construction of Cancer Treatment Facilities to Uplift the Demand for Cancer Pain Management – The countries in the Middle Eastern & Asia-Pacific region are emerging as medical tourism hubs since these countries provide healthcare facilities at relatively lower prices. As a result, cancer patients from European & North American countries are increasingly getting their treatment in these countries. Therefore, the governments across these regions are investing heavily to improvise healthcare infrastructure to cater to this growing need for cancer treatment. As a result, these countries are registering growth in the construction of several new hospitals & healthcare facilities. For instance:

  • The government of the UAE announced the establishment of Hamdan Bin Rashid Cancer Hospital, a 250-bed cancer facility by 2026.

This rising construction of treatment centers & healthcare facilities would provide a prospect for the key market players to supply their drugs & therapy solutions in these countries. This would consequently result in enlarging the Global Cancer Pain Management market size.

Further, several nations would witness progression in the number of cancer patients in forthcoming years due to rising geriatric population. As a result, the governments of these countries would focus on building more cancer treatment facilities. This would conseuqntly amplify the demand for the cancer pain management solution during forecast period.

Global Cancer Pain Management Market Challenge:

Adverse Side Effects of Opioid Medication Hampers the Market GrowthThe patients suffering from cancer generally undergo treatment & take opioid medications. This medication helps in relieving cancer pain. However, the continuous usage of these drugs has negative impacts on the vital organs, which results in kidney or Organ failure. Therefore, cancer patients restrain themselves from opting for the high dosage of these drugs, resulting in lower sales of opioid cancer-related drugs. In addition, the continuous usage of these drugs results in addiction & depression, which is concerning for the patients. According to the study conducted by the American Medical Association (AMA), in 2022, around 3%-19% of total cancer patients develop an addiction to opioid medications. Therefore, health practitioners, restrain themselves from using these drugs and usually prefer alternative medicine to cope with cancer pain. This is resulting in a slowdown in the demand for opioid medication, hampering the Global Cancer Management market.

Global Cancer Pain Management Market Trend:

Rising Inclination Towards Non-Opioid Therapies to Propel Market Growth – In recent years, there have been rising concerns regarding opioid misuse & dependence. These drugs & therapies are addictive and result in some other side effects. As a result, the market players are introducing the drug with fewer side effects on health. For instance, in 2024, Vertex, a leading market player announced a positive & successful clinical trial of its non-opioid drug. This drug has a higher efficacy & offers an encouraging health result and also minimizes side effects. Therefore, cancer patients are increasingly shifting towards these alternative & powerful cancer pain management medicines, uplifting the Global Cancer Pain Management Market.

Furthermore, several reputed medical organizations and research centers, like the American Pain Society (APS), the European Pain Federation (EFIC), etc., are increasingly developing clinical guidelines and protocols to encourage the adoption of non-opioid medications and adjuvant therapies for cancer pain management. The increasing implementation of government authorities' initiatives would continue to encourage the adoption of these therapies & medicines in healthcare facilities in the forthcoming years.

Global Cancer Pain Management Market (2024-30): Segmentation Analysis

The Global Cancer Pain Management Market study by MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the regional level. In accordance to the analysis, the market has been further classified as:

Based on the Drug Class:

  • Opioids
    • Morphine
    • Oxycodone
    • Fentanyl
    • Others (Methadone, Tapentadol, etc.)
  • Non-Opioids
    • Acetaminophen
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
      • Ibuprofen
      • Naproxen
      • Others (Diclofenac, Ketorolac, etc.)
    • Antidepressants
    • Others (Steroids, Anti-convulsants, etc.)

Among them, the Opioids segment held a major share in the Global Cancer Pain Management Market. The growth has been attributed to the presence of a large number of patients with different cancer types such as prostate, breast, and others experiencing pain as a serious consequence of cancer & its treatment. According to the International Association for the Study of Pain, in 2024, there are approximately one-third of adults who are actively receiving treatment for cancer and two-thirds of those with advanced malignant disease experience pain. Opioids are highly effective for the management of moderate to severe pain particularly in those at an advanced stage of disease. As a result, their usage has witnessed growth, propelling the overall opioid segment market.

Based on Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Stomach
  • Colorectal
  • Others (Blood Cancer, Prostate Cancer, etc.)

Of them all, Breast Cancer held a significant market share in the Cancer Pain Management Market. In the developed economy, the awareness among women regarding breast cancer is less, and usually, women are As a result, the risks of getting affected by breast cancer are increasing. According to the research by Global Cancer Observatory, in 2022-2023, there were more than 2 million new cases of breast cancer across the world. Therefore, the patients suffering from these cancers undergo the treatment and rely heavily on cancer pain management therapies & drugs.

Further, the shift towards a hectic lifestyle due to increasing workload & less health awareness among women would elevate the number of cancer patients in the forthcoming years. Therefore, the demand for cancer pain management therapies & drugs for breast cancer patients would increase during 2024-2030, enhancing the market share of breast cancer in the Global Cancer Pain Management Market.

Global Cancer Pain Management Market (2024-30): Regional Projection

Geographically, the Global Cancer Pain Management Market expands across:

  • North America
  • South America
  • Europe
  • The Middle East & Rest of Africa
  • Asia-Pacific

Geographically, North America accounts for the largest market share in the Global Cancer Pain Management Market. Nations in the North American region have a higher number of cancer cases due to the rising obesity & diabetic population. According to the statistics provided by the Global Cancer Observatory, in 2022, the countries in North America witnessed more than 2 million new cancer cases. As a result, the demand for cancer management drugs & therapies in North America is higher. Further, the number of individuals suffering from cancer would elevate in North America. Per the study conducted by Global Cancer Observatory, the number of individuals will reach more than 32 million by 2045. Therefore, the increasing number of cancer patients would propagate the demand for cancer pain management drugs, escalating the regional market growth during the forecast period.

Global Cancer Pain Management Industry Recent Development:

  • 2022: Strides Pharma received the US Food and Drug Administration approval for Ibuprofen suspension, a nonsteroidal anti-inflammatory drug (NSAID) used as a painkiller.

Gain a Competitive Edge with Our Global Cancer Pain Management Market Report

  • The Global Cancer Pain Management Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  • This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  • The Global Cancer Pain Management Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The Global Cancer Pain Management Market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2030.

   A. Mounting cancer cases across the globe is a prominent factor expected to drive the Global Cancer Pain Management Market during 2024-30.

   A. Daiichi Sankyo Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals, Inc., Lupin, Forte Bio-Pharma LLC, Mallinckrodt Pharmaceuticals, Collegium Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Napp Pharmaceuticals, Zentiva Group, Mundipharma International, G.L. Pharma, and Others are the top players in the Global Cancer Pain Management Market.

   A. Opioids held the largest share of the Global Cancer Pain Management Market.

   A. North America would present growth prospects in the Global Cancer Pain Management Market during 2024-30.

   A. Rising inclination towards non-opioid therapies is one of the key trends shaping the growth of the Global Cancer Pain Management Market.

   A. Rising construction of cancer treatment facilities is one of the growth opportunities in the Global Cancer Pain Management Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Cancer Pain Management Market Trends & Developments
  5. Global Cancer Pain Management Market Dynamics
    1. Drivers
    2. Challenges
  6. Global Cancer Pain Management Market Hotspot & Opportunities
  7. Global Cancer Pain Management Market Supply Chain Analysis
  8. Global Cancer Pain Management Market Regulations & Policy
  9. Global Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Drug Class
        1. Opioids- Market Size & Forecast 2019-2030, USD Million
          1. Morphine- Market Size & Forecast 2019-2030, USD Million
          2. Oxycodone- Market Size & Forecast 2019-2030, USD Million
          3. Fentanyl- Market Size & Forecast 2019-2030, USD Million
          4. Others (Methadone, Tapentadol, etc.)- Market Size & Forecast 2019-2030, USD Million
        2. Non-Opioids- Market Size & Forecast 2019-2030, USD Million
          1. Acetaminophen- Market Size & Forecast 2019-2030, USD Million
          2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)- Market Size & Forecast 2019-2030, USD Million
            1. Ibuprofen- Market Size & Forecast 2019-2030, USD Million
            2. Naproxen- Market Size & Forecast 2019-2030, USD Million
            3. Others (Diclofenac, Ketorolac, etc.) - Market Size & Forecast 2019-2030, USD Million
          3. Antidepressants- Market Size & Forecast 2019-2030, USD Million
          4. Others (Steroids, Anti-convulsants, etc.)- Market Size & Forecast 2019-2030, USD Million
      2. By Route of Administration
        1. Oral- Market Size & Forecast 2019-2030, USD Million
        2. Injectable- Market Size & Forecast 2019-2030, USD Million
        3. Transdermal- Market Size & Forecast 2019-2030, USD Million
        4. Others (Intranasal, Intrathecal, etc.)- Market Size & Forecast 2019-2030, USD Million
      3. By Cancer Type
        1. Lung Cancer- Market Size & Forecast 2019-2030, USD Million
        2. Breast Cancer- Market Size & Forecast 2019-2030, USD Million
        3. Stomach- Market Size & Forecast 2019-2030, USD Million
        4. Colorectal- Market Size & Forecast 2019-2030, USD Million
        5. Others (Blood Cancer, Prostate Cancer, etc.)- Market Size & Forecast 2019-2030, USD Million)
      4. By Distribution Channel
        1. Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
        2. Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
        3. Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
      5.  By End User
        1. Hospitals- Market Size & Forecast 2019-2030, USD Million
        2. Homecare- Market Size & Forecast 2019-2030, USD Million
        3. Specialty Clinics- Market Size & Forecast 2019-2030, USD Million
        4. Others (Research Organisations, Palliative Care Centers, etc.)- Market Size & Forecast 2019-2030, USD Million
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      7. By Competition
        1. Competition Characteristics
        2. Market Share of Companies
  10. North America Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Canada Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Mexico Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  11. South America Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  12. Europe Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. The UK Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. France Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. Spain Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. Italy Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  13. The Middle East & Africa Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. South Africa Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  14. Asia-Pacific Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. China
        2. Japan
        3. Australia
        4. South Korea
        5. India
        6. Rest of Asia-Pacific
    3. China Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Japan Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Australia Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. South Korea Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. India Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  15. Global Cancer Pain Management Market Key Strategic Imperatives for Growth & Success
  16. Competitive Outlook
    1. Company Profiles
      1. Daiichi Sankyo Company Limited
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Teva Pharmaceutical Industries Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Pfizer Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Boehringer Ingelheim International GmbH
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Amneal Pharmaceuticals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Lupin
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Forte Bio-Pharma LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Mallinckrodt Pharmaceuticals 
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Collegium Pharmaceuticals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Johnson & Johnson Services, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Dr. Reddy’s Laboratories Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Napp Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Zentiva Group
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Mundipharma International
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. G.L. Pharma
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer

 


Cancer Pain Management Market Segment